Comparison of methods for measuring cardiac contractility
Organ transplantation is a lifesaving procedure, yet the demand for transplants far exceeds the available supply. Each year, nearly seven thousand patients in the United States die while waiting for an organ transplant . Developing heart muscles
2. Miniaturizing biological samples and products
Size of engineered tissue (ET) varies based on research needs. To systematically screen and analyze a large number of parameters that determine tissue function, the size of ETs has to be defined based on the required throughputs and phenotying assays for the tissue function analysis. Fully-grown cardiac muscle cells in three dimensional matrices are at least 100 um in length along their longitudinal axis . Therefore, engineered heart tissues (EHTs) should be at least several times larger than the size of single cells in order to form multi-cellular functional cardiac muscles. In addition, the statistical significance of data improves significantly when using multi-cellular tissues rather than single cells  because the tissue samples contain from tens of thousands to over a million cells. The functional assay data collected using tissues represents an average function of many cells embedded in the tissues. By applying the photolithographical techniques, smaller, micro-scale (50-200 um) engineered tissues can be fabricated  to mimic intricate shapes of native tissues. However, in these micro-scale tissues, it is yet to be determined if there is an improvement of the statistical significance of functional data over that from single cells. At present, ETs in millimeter scale have been used for the functional assays with relatively good data reproducibility  . By using ETs, a statistically significant data can be obtained using only 4-8 samples  instead of collecting ranging 60-600 data points per well in cell-based assays .
Unlike the rapid prototyping of parts with synthetic materials, the prototyping of engineered tissues with live cells has to consider the behavior of tissues after fabrication in a given culture condition. Cells are a vital element of developing functional organs and tissues. While consuming nutrients and receiving extracellular stimuli, the cells synthesize, secrete, and degrade proteins, divide, and remodel tissues. Therefore, developers of engineered tissue have to take these aspects into account for the design and development of engineered tissue samples and products. Behaviors of cells have been studied extensively to understand the molecular mechanisms by which biological functions of cell are regulated . Because the cell behavior should underlie function of tissues and organs, the vast amount of information that has been accumulated through studies of cells should be used to understand tissue and organ function. However, some recent findings indicate that biology of cells cultured in two dimension (2D) is not entirely the same as that of cells cultured in a three dimensional (3D) environment, which is more similar to the
3. 2D vs 3D cell based analysis
Even though cells cultured on a 2D surface have been assumed to closely resemble those in tissues and organs, in some aspects they are quite different from those found
When testing mechanical signaling, the tissues are subjected to mechanical deformations including pushing and stretching. An application of cyclic mechanical stretch to cardiac myocytes and fibroblasts up-regulates various signal transduction pathways through Rho/ROCK activation [17, 18]. Activation of extracellular signal-regulated kinases (ERKs) and up-regulation of an immediate early gene family of transcription factors, and c-fos  are well-characterized early responses of cells to the stretching. Up-regulated cellular processes including protein synthesis  and myofibril organization  are also apparent. The Rho/ROCK signaling pathway also regulates a hypertrophic response in cultured cardiac myocytes after application of soluble factors such as endothelin-1 treatment . Therefore, an intricate balance orchestrated by soluble stimuli, mechanical deformation, and extracellular stiffness dictates the tissue development.
The tissue can function normally under homeostasis, at which the mechanical balance between extra- and intra-cellular activities is balanced. The homeostasis can be shifted by aging or other long term processes but is a quasi-steady state that is required for a tissue’s physiological function. For example, physiological wound healing restores the homeostasis in the granulation tissue – fibrous connective tissue of healing wounds – by active fibroblasts contracting open wounds, secreting factors and hormones, and degrading ECMs to reconstruct the damaged tissues . Pathological wound healing, such as keloids and scars in skin , fails to restore the homeostasis. A schematic description of potential network system is in shown in Figure 1. Intracellular molecular sensors, such as the src family kinase substrate p130Cas , detect the stiffness of extracellular environment to initiate its down-stream signaling events including Ca2+ release, kinase activity, and gene regulation. Expressions of various genes are up-regulated through translocation of transcription factors from cytoplasm into nucleus. Furthermore the gene expression can be coupled to cell contraction. For instance, during the formation of actin stress-fibers in contracting fibroblasts, the balance of actin pools is shifted from a high prevalence of the monomer state to increased polymer levels. This balance shift frees up myocardin-related transcription factors (MRTF)-A, which are bound to monomer actins, and the unbound MRTF-As translocate into nucleus to promote gene expression. Therefore, MRTF-A’s downstream up-regulation of wound healing gene-family including collagen type I a1 is tightly coupled to the state of actin polymerization (F- and G- actin ratio) in fibroblasts .
In parallel with changing the mechanical environment, the soluble factors, such as TGF β1, binding to their specific receptors initiate the similar downstream signaling events [27, 28]. Depending on the signaling pathways, the initial signal strength can be amplified. One of recent observations indicates that signal strength is amplified in three-tiered kinase module of Raf-MEK(mitogen-activated protein kinase or extracellular signal-regulated kinase kinase)-ERK (extracellular signal-regulated kinase) by increasing concentrations of kinases involving in downstream (e.g., 1:3:6 = raf-1:MEK:ERK) in COS cells . The soluble and mechanical stimuli result in the development of contractility by actin-myosin interactions, which is one of end-points of the signaling pathways. We hypothesize that the activities of actin-myosin interactions is a part of feedback mechanism by which cells sense the strength of mechanical stimuli and stiffness of extracellular space . Integrin-linked kinase and ECM protein, tenascin-C, have been demonstrated to be a part of the mechanical sensory systems in zebrafish heart , skeletal muscles , and fibroblasts .
As demonstrated elegantly for p130Cas , a simple analogy of the biological sensory mechanism is represented as a mechanical strain gauge that measures applied forces by detecting small deformations of proteins. Depending on an elastic strength of the gauge (i.e., protein), its sensitivity can be varied. In general the sensitivity becomes higher by reducing the elasticity of the gauge material since it can deform more with a same applied force. We and others  assume that the molecular strain gauges are coupled to the actin-myosin forming stress fibers whose elasticity or stiffness is modulated by activity of myosin. The receptor activation initiated by binding of various soluble factors triggers and modulates myosin activity. Therefore, the sensitivity of the mechanical sensor can be modulated. Eventually the mechanical properties of cell and extracellular matrix reach a steady state to find homeostasis. However, its specific mechanism by which sensors can modulate their sensitivity and determination of the homeostasis are yet to be elucidated. Nevertheless, the concept of the establishment of homeostasis between the cells and ECM comprising “tissue” should be considered carefully while designing and developing the functional tissues
4. Cardiac tissue phenotyping and their potential to assay-automation
The assay system by which developers can evaluate the functional improvement that results from optimizing the tissue fabrication and culture conditions will have to accurately observe the physiological functions of cardiac tissues. The contractility of cardiac tissues is the most fundamental functional readout that can indicate the functional improvement by varying the tissue fabrication conditions. The regulatory system of cardiac contractility should also be reconstituted in the engineered tissues, which will be evaluated through rapid prototyping. As listed in Table 1, EHT-based contractility assessment is ideal for assessing cardiac functions in high-throughput, as compared to the other techniques that have traditionally been used to assess the function of myocytes, myocardium, and isolated hearts. Each method has its own advantages and disadvantages. The assay results using isolated adult cells and papillary muscles will continue to serve as references for the expected muscle cell and tissue contractility and its regulation. However, they can not report the tissue functions. Cardiac contractility assays using isolated Langendorff preparation has been gradually replaced by hemodynamic measurements using pressure-volume conductance catheters  as well as echo cardiography. Nevertheless, the whole heart functional assay can be used to assess functional improvement that results from the tissue transplantation.
|Sample viability period||Weeks to months||~6 hrs||~6-8 hrs||~8 hrs|
|Contractility measurements with preload.||Yes (various)||No *||Yes (various)||Yes (various, PV loop)|
|Optical assessment of live cells||Yes (easy)||Yes (easy)||Yes (not easy)||No (generally)|
|High throughput testing||Yes||Yes||No||No|
|Sample damage by isolation||No||Yes||Yes||Yes|
|Comments||Reconstituted system||High data variance||Widely used standards.|
|* Isolated adult cells can be stretched by carbon fiber techniques . High throughput measurements and range of stretching are limited.|
Once the EHTs start contracting, they maintain contractility for at least 2-3 weeks. Assessment of acute and chronic changes in contractility and cell physiology can thus be monitored for long periods using EHTs. Even though EHTs are artificially reconstituted organoids, their histological structure and functional properties are similar to those in native myocardium [5, 36]. Each EHT is fabricated by pouring a gel solution containing predefined concentrations of cells, matrix proteins, and growth factors into a precisely machined well . Since 1993, similar engineered tissues have been used as a model system to study signal transduction pathways that regulate contractility of fibroblasts , smooth muscle cells, skeletal muscle cells . We were the first to introduce the use of tissue models to determine effective drug doses  and have recently extended the application of this technology to include phenotypic screening . We demonstrated the phenotypic difference in tissue mechanics between wildtype cells and mutant cells with truncated α1 integrin . We also extended the applications of engineered tissue models by creating cardiac tissue constructs . Recently, we introduced the concept of growing mini-tissues in 96-well plates for high-throughput drug screening . Initially engineered heart tissues were fabricated using a tissue fabrication mold that cast hydrogel into a ring . To miniaturize the tissues, we developed tissue fabrication wells similar to those used in 96-well format. The center-to-center distance of 96-well plates is 9 millimeters. We developed 8mm x 8mm square wells to fabricate the engineered tissues. We demonstrated the automation of contractile measurements of EHTs to improve the productivity of the proposed studies. The generation of EHTs using pluripotent stem cells will open up the new pathways to develop engineered tissues using human cells. However, there are several issues that need to be solved before benefitting highly promising technology.
5. Multi cell types require functional cardiac patches using iPSCs
Human iPSCs, which are generated by genetic reprogramming of somatic cells to an infinitely self-renewing pluripotent state [43, 44], offer an excellent source for robust generation of large numbers of human cardiac myocytes (CMs), endothelial cells (ECs) and fibroblasts (FBs), which are all needed for producing a vital EHT
Because of the requirement of multi cell types to fabricate functional cardiac patches, the high throughput rapid prototyping system can contribute to identifying the optimal combination of cell types to fabricate the best cardiac patches. Not only varying the number of CMs, ECs, and FBs to initiate the fabrication, the response to each cell type to various hormones, growth factors, and mechanical environment will have to be screened again to find the best combinations. Therefore, a rapid prototyping system that can screen various test conditions will be critically needed to establish functional tissues with desired phenotypes.
Systematically optimizing a tissue-fabrication protocol will require an iterative process of changing the parameters of fabrication and tissue culture conditions incrementally after measuring the resulting functional improvement. To test a large number of these parameters to the best outcome, many tissues have to be fabricated and their function has to be evaluated in high-throughput. To achieve this prototyping cost-effectively, the samples have to be miniaturized. Most importantly, establishing the tissue homeostasis in the engineered tissue has to be achieved either before implantation or by taking account how tissue homeostasis will be established with the acceptor’s existing tissue.
8. Sources of funding
This research was supported in part by NIH GM087784 grant
We thank Mr. David Glaubke for his contribution to the careful reading of manuscript and editorial comments.
Roberts M. S. 2010Improving the Supply of Donor Organs. JAMA: The Journal of the American Medical Association. 304(23): 2643 2644
, Yasuda S. I. et al. novel A. method to. study contraction. characteristics of. a. single cardiac. myocyte using. carbon fibers. 2001 H1442 H1446
Zimmermann, W.-H., et al., Heart muscle engineering: An update on cardiac muscle replacement therapy.Cardiovascular , 2006 419 429
Pediatric Heart Surgery. , Zimmermann W. H. Cesnjevar R. Cardiac Tissue. Engineering Implications. for Pediatric. Heart Surgery. 2009 716 723
Asnes, C.F., et al., Reconstitution of the Frank-Starling mechanism in engineered heart tissues.Biophys J, 2006 1800 1810
, Wakatsuki T. Lieder K. W. Annac A. Engineered Tissue. Models Innovative. Tools for. Early-Stage-Dense Information. High-Throughput Screening. for Drug. Discovery 2006Nov/Dec).
Nelson, C.M., J.L. Inman, and M.J. Bissell, Three-dimensional lithographically defined organotypic tissue arrays for quantitative analysis of morphogenesis and neoplastic progression., 2008 674 678
Vandenburgh, H., High-Content Drug Screening with Engineered MusculoskeletalTissues. Part B: Reviews, 2010 55 64
Marquez, J.P., et al., High-Throughput Measurements of HydrogelTissue Construct Mechanics. Part C Methods, 2009
Morelock, M.M., et al., Statistics of Assay Validation in High Throughput Cell Imaging of Nuclear Factor κB Nuclear Translocation., 2005 483 499
, From molecular to modular cell biology. . , Hartwell, L.H. et al.
Cukierman, E., et al., Taking cell-matrix adhesions to the third dimension., 2001 1708 1712
Engler, A.J., et al., Extracellular matrix elasticity directs stem cell differentiation. , 2007 335
Pedersen, J.A. and M.A. Swartz, Mechanobiology in the third dimension., 2005 1469 1490
, Pankov R. et al. Rac A. switch regulates. random versus. directionally persistent. cell migration. 2005 793 802
Green, J.A. and K.M. Yamada, Three-dimensional microenvironments modulate fibroblast signaling responses., 2007 1293 1298
Torsoni, A.S., et al., RhoA/ROCK signaling is critical to FAK activation by cyclic stretch in cardiac myocytes., 2005 H1488 H1496
, Sarasa-Renedo A. Tunç-Civelek V. Chiquet M. Role of. Rho A. R. O. C. K-dependent actin. contractility in. the induction. of-C tenascin. by cyclic. tensile strain. 2006 1361 1370
Ueyama, T., et al., Activated RhoA stimulates c-fos gene expression in myocardial cells., 1997 672 678
Circ Res, Aikawa R. et al. Rho family. small G. proteins play. critical roles. in mechanical. stress-induced hypertrophic. responses in. cardiac myocytes. 1999 458 466
Hoshijima, M., et al., The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes.Involvement of Rho kinase. , 1998 7725 7730
Yanazume, T., et al., Rho/ROCK pathway contributes to the activation of extracellular signal-regulated kinase/GATA-4 during myocardial cell hypertrophy.J Biol Chem, 2002 8618 8625
Tomasek, J.J., et al., Myofibroblasts and mechano-regulation of connective tissue remodelling., 2002 349 363
Slemp, A.E. and R.E. Kirschner, Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management., 2006 396 402mop.0000236389.41462.ef.
Sawada, Y., et al., Force Sensing by Mechanical Extension of the Src Family Kinase Substrate p130Cas., 2006 1015 1026
Small, E.M., et al., Myocardin-Related Transcription Factor-A Controls Myofibroblast Activation and Fibrosis in Response to Myocardial Infarction., 2010 294 304
, Shi Y. Massagué J. Mechanisms of. T. G. F-[beta] Signaling. from Cell. Membrane to. the Nucleus. 2003 685 700
Du, J., et al., TRPM7-Mediated Ca2+ Signals Confer Fibrogenesis in Human Atrial Fibrillation., 2010 992 1003
Sturm, O.E., et al., The Mammalian MAPK/ERK Pathway Exhibits Properties of a Negative Feedback Amplifier.Sci. Signal., 2010. 3(153): p. ra90-.
, Wakatsuki T. Elson E. L. Reciprocal interactions. between cells. extracellular matrix. during remodeling. of tissue. constructs 2003 593 605
Bendig, G., et al., Integrin-linked kinase, a novel component of the cardiac mechanical stretch sensor, controls contractility in the zebrafish heart., 2006 2361 2372
KJÆR, M., Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading., 2004 649 698
Maier, S., et al., Tenascin-C induction by cyclic strain requires integrin-linked kinase.Biochimica et Biophysica Acta (BBA)- , 2008 1150 1162
Russo, R., et al., Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma., 2007 1136 1141
Pacher, P., et al., Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats., 2008 1422 1434
Eschenhagen T. Zimmermann W. H. Engineering myocardial. tissue Circ. Res 2005 1220 1231
Kolodney, M.S. and E.L. Elson, Correlation of myosin light chain phosphorylation with isometric contraction of fibroblasts., 1993 23850 23855
J Cell Sci, Wakatsuki T. et al. Effects of. cytochalasin D. latrunculin B. on mechanical. properties of. cells 2001Pt 5): 1025 1036
Wakatsuki, T., J.A. Fee, and E.L. Elson, Phenotypic screening for pharmaceuticals using tissue constructs., 2004 181 189
Zutter, M.M., et al., Collagen receptor control of epithelial morphogenesis and cell cycle progression.Am J Pathol, 1999 927 940
Eschenhagen, T., et al., Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system., 1997 683 694
Flanagan, N., Tissue Models Boost Drug Discovery Efforts; Eliminating Toxic and Ineffective Compounds at an Early Stage., 2005 1
Takahashi, K., et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors., 2007 861 872
Yu, J., et al., Human induced pluripotent stem cells free of vector and transgene sequences., 2009 797 801
Stevens, K.R., et al., Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue., 2009 16568 16573
Yang, P.T., et al., Wnt signaling requires retromer-dependent recycling of MIG-14/Wntless in Wnt-producing cells., 2008 140 147
Laflamme, M.A., et al., Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts., 2007 1015 1024
Caspi, O., et al., Tissue engineering of vascularized cardiac muscle from human embryonic stem cells., 2007 263 272